myeloma

American Society of Clinical Oncology; Clinical Cancer Advances 2018: ASCO's Annual Report on Progress Against Cancer
January 30, 2018 · Greg Guthrie, ASCO staff
The 2018 Clinical Cancer Advances report of the American Society of Clinical Oncology has crowned an adoptive cell immunotherapy as its Advance of the Year. What is this innovative cancer treatment? What are the risks and benefits? Read More >>
2017 ASCO Annual Meeting, Research Round Up Podcast Series
September 5, 2017
Lineagotica Associate Editors discuss exciting new cancer research in the final Research Round Up podcast of the summer. Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 5, 2017 · Greg Guthrie, ASCO staff
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Today’s key research highlights include CAR T-cell therapy for multiple myeloma, immune checkpoint inhibitors for mesothelioma, and targeted therapy advances for non-small cell lung cancer and HER2-positive breast cancer. Read More >>
2016 ASCO Annual Meeting: Collective Wisdom #ASCO16
June 5, 2016 · Lindsay Dudbridge, ASCO staff
Oncology professionals from around the world are in Chicago for the ASCO Annual Meeting. There, they will discuss the latest advances and newest thoughts in cancer research. Today’s highlights cover research that could potentially have the greatest impact to patient care for breast cancer, glioblastoma, neuroblastoma, and multiple myeloma. Read More >>
2016 ASCO Annual Meeting: Collective Wisdom #ASCO16
May 18, 2016 · Lindsay Dudbridge, ASCO staff
From June 3 to June 7, oncology professionals from around the world will meet to discuss the latest in cancer research. If you can’t wait to learn about the latest research, check here for early highlights released in advance of the 2016 ASCO Annual Meeting. Read More >>

Pages